 
|
Kurt Schemers - Interviews:
Paul C. Desjourdy, President and CEO of
Symbollon Pharmaceuticals, Inc. (bb: SYMBA)
|
Shares Outstanding: 7,300,000
Float: 6,682,000 (approximately)
*52-week Range: $.65 - $2.00
*Source: Knobias.com
|
|
Symbollon Pharmaceuticals, Inc.
(bb: SYMBA)
Head Office
37 Loring Drive
Framingham, MA 01702
Attn: Paul C. Desjourdy, President
Voice: (508) 620-7676 x202
Fax: (508) 620-7111
Email: Paul Desjourdy
Web site: www.symbollon.com
|
|
Listen To Traders Nation LIVE Every Week Day Morning
|
Traders Nation 'LIVE' - The Fastest Growing Syndicated Radio Talk Show For Smallcap Stocks. Hosted by Kurt Schemers - More Info |
About Symbollon Pharmaceuticals, Inc.
Symbollon Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary drugs based on its molecular iodine technology. Symbollon already has completed Phase I and II clinical trials evaluating IoGen as a potential treatment for moderate to severe cyclic pain and tenderness (clinical mastalgia) associated with fibrocystic breast disease (FBD). FBD is a condition that affects approximately 20 million to 33 million women in the U.S., and there are approximately 7 million to 13 million women suffering from clinical cyclic mastalgia. The Company believes IoGen also may be useful in treating and/or preventing endometriosis, ovarian cysts, and premenopausal breast cancer.
In female health, Symbollon has developed a proprietary oral tablet based on our technology that generates I2 in situ (the stomach of the patient). We refer to this drug as IoGen. In 2000, Symbollon completed Phase I and II clinical trials evaluating IoGen as a potential treatment for fibrocystic breast disease. Phase III pivotal trials will be conducted in 2005. We believe that IoGen may also be useful for the treatment and prevention of other types of excess cell growth in female reproductive tissue, such as endometriosis, ovarian cysts and pre-menopausal breast cancer.
Our efforts in infection control have resulted in one commercial product to date. Launched in 1995, IodoZyme is a bovine teat sanitizer sold through our marketing partner, West Agro, Inc.
In the future, Symbollon intends to investigate the potential effectiveness of its technology in such antimicrobial applications as dermatology, oral care, urinary tract infection and wound care.
Paul C. Desjourdy
President, Chief Executive Officer
Mr. Desjourdy has served as Chief Executive Officer of the Company since June 2005, President and General Counsel of the Company since December 1999, Chief Financial Officer since September 1993, and Treasurer from May 1994. Prior to that time, he held the titles of Chief Operating Officer of the Company from December 1999 to June 2005, Executive Vice President of the Company from July 1996 to December 1999, and Vice-President - Finance and Administration of the Company from September 1993 to July 1996. From September 1989 to September 1993, Mr. Desjourdy was an attorney at the law firm of Choate Hall & Stewart. From September 1983 to September 1986, Mr. Desjourdy was a certified public accountant at Arthur Andersen & Co. Mr. Desjourdy holds a J.D. from Boston College and a Master of Finance from Bentley College.
Jack H Kessler, Ph.D.
Chief Scientific Officer, Secretary and Chairman of the Board of Directors
Dr. Kessler is the founder of the Company and has served as Chief Scientific Officer, Secretary, and a director since the Company's move to Massachusetts in May 1991, and as Chairman of the Board of Directors since May 1996. Dr. Kessler held the title of Chief Executive Officer of the Company from December 1999 to June 2005, Executive Vice-President of the Company from May 1991 to December 1999, and from the Company�s formation in Illinois in 1986 until 1991 Dr Kessler was the Company's sole stockholder and served as its sole officer and director.
Dr. Eskin Joins Symbollon as Scientific Advisor -- Market Wire (Mon, Dec 5)
Forum Alert: Symbollon Pharmaceuticals, Inc. will Present at the Informed Investors Biotechnology & Healthcare Investor Forum at The Hyatt Regency in San Francisco on Wednesday, December 7, 2005, 10:15 am PST -- Business Wire (Mon, Nov 21)
Symbollon Pharmaceuticals, Inc. to Start Study Focused on Proliferative Benign Breast Tissue -- Market Wire (Thu, Oct 20)
|
Compensation: $12,000 by Symbollon Pharmaceuticals, Inc. (bb: SYMBA). Read Carefully and Think Clearly When Investing In Any Stock. TradersNation.com is an independent electronic publication providing both information and factual analysis on selected companies. The opinions and analysis included herein or in our audio programs are based on sources believed to be reliable and in good faith but no representation or warranty, expressed or implied, is made as to their accuracy, completeness or correctness. TradersNation.com, it's owners, employees or officers are not licensed brokers, broker dealers, investment advisers or underwriters.
This information read at TradersNation.com or it's newsletters or heard on "Traders Nation" is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. The foregoing discussion contains forward looking statements which are based on current expectations and differences can be expected.
The information contained herein or heard on "Traders Nation" may have been provided by the Company to TradersNation.com for information purposes only. Readers or listeners are urged to consult with independent financial advisors with respect to an investment in the issues mentioned herein. Investors should review a complete information package on the Company, which should include, but not be limited to, the Company's annual report, quarterly report, press releases, as well as all regulatory filings. All information contained in this report or audio program "Traders Nation" should be independently verified with the Company mentioned herein. Any opinions expressed in this report or heard on "Traders Nation" are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
TradersNation.com nor its officers, directors, partners or employees / consultants accept no liability whatsoever for any direct or consequential loss arising from any use of this report or information heard on "Traders Nation". TradersNation.com affiliates, agents and/or family may have interests or positions in equity securities of the companies reviewed in this publication or presented on "Traders Nation", some or all of which may have been acquired prior to the dissemination of this report, and may increase or decrease these positions at any time.
Investing in growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or impaired due to the speculative nature of the companies profiled.
TradersNation.com may or may not have purchased, sold or profiled via email stocks featured on it's website. TradersNation.com reviews and scours hundreds of stocks in a monthly period and can not participate in every find or send out every find via email. TradersNation.com feels that by doing so it would dilute interest in it's electronic emails or quality of the audio programming on "Traders Nation".
We encourage the reader to review the investing information available with the Securities and Exchange Commission ("SEC") at http://www.sec.gov and / or the National Association of Securities Dealers ("NASD") at http://www.nasdr.com. Readers can review all public filings by the Company at the SEC's EDGAR page.
The NASD has published information on how to invest carefully at its web site.
Finally, investing is a very serious business and you should treat it as one. Never invest money you aren't willing to risk to loss. There are many pitfalls to investing, your continued learning in the stock market is your best advantage.
Forward-Looking Statements
This news release may contain forward-looking statements, which involve risks and uncertainties. Accordingly, no assurance can be given that the actual events and results will not be materially different than the anticipated results described in the forward-looking statement. There are a number of important factors that could cause actual results to differ materially from those expressed in any forward-looking statements made by the Company. These factors include the Company's success in its business and operations; the activities of new or existing competitors, the ability to attract and retain employees and strategic partners, the ability to leverage intangible assets, the ability to complete new projects at planned costs and on planned schedules and adoption of the Internet as a medium of commerce, communications and learning. Investors are also directed to consider other risks and uncertainties discussed in documents filed by the company with the Securities and Exchange Commission. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements, which may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
All logo's, copyrights, trademarks, and corporate identities respectfully and rightful belong to all owners listed or replicated herewithin.
|
Back To TOP
Report A Site Problem Here
All original interviews whether they be audio or video programs are copyright protected
intellectual property of Financial Network Media LLC and TradersNation.com.
Reproduction in whole or in part is strictly forbidden without written permission of
the publisher. Linking to audio or video presentations on TradersNation.com is strictly
forbidden without a license or agreement prior to capturing our copyright protected material.
Financial Network Media LLC - A Financial Broadcasting Company
All Rights Reserved 2001 - 2009
This Sites Disclaimer | Privacy | Contact | Contact Legal | Spam | Advertise With Us
© Associated Press. All rights reserved.
Copyright © 2009 QuoteMedia, Inc.
Dedicated - All market data delayed 20 minutes.
|
|
|
|
Wyncrest Group, Inc. (otc: WYCT)
Wyncrest is a growing holding company comprised of subsidiaries within the financial and insurance industry segments. From life insurance and long term care to student and sports insurance and employee group benefits, Wyncrest Group's broad financial product and service offerings provide economic protection and growth opportunities for investors.
  Broadcast Interview
|
|
|
Magnum D'Or Resources (bb: MDOR)
Through its vision, leadership, and development activities Magnum D'Or Resources will become an industry leader in recycling technology, solid waste solutions, and automated facility operations. In its efforts to become a global waste management leader, it believes that by applying its patented processes to a broad range of waste applications, it can provide much needed ecological benefits to most of the world's industrialized nations.
Broadcast Interview
|
|
|
Elephant Talk Communications, Inc. (bb: ETAK)
Elephant Talk Communications is positioning itself as an international telecom operator and enabler/systems integrator to the multimedia industry by facilitating the distribution of all forms of content, as well as mobile and fixed-telecom services, to global telecommunications consumers.
Broadcast Interview
|
|
|
BioElectronics Corporation (otc: BIEL)
BioElectronics Corporation (OTCPK: BIEL) is the maker of unique inexpensive, drug free, anti-inflammatory patches for a broad range of unmet soft tissue medical needs. The patches have an embedded microchip and battery that deliver pulsed electromagnetic energy, a clinically proven and widely accepted anti-inflammatory and pain relief therapy that, previously, has only been possible to obtain from large, facility-based equipment.
Broadcast Interview
|
|
|
CHDT Corp. (bb: CHDO)
Originally formed in Colorado in 1989, it was reincorporated in Florida in 2004 under the name China Direct Trading Corporation.
In June of 2007, the name was changed to CHDT Corporation to properly reflect the fact that although global sourcing with China will continue to play an important role in many business units, other units will likely not be involved in China sourcing in the future.
Broadcast Interview
|
|
|
CleanTech Biofuels (bb: CLTH)
CleanTech Biofuels, Inc. holds exclusive licenses to a pair of technologies that offer significant advances in converting municipal solid waste (MSW) into ethanol. The first of these technologies involves the treatment of MSW at temperature and pressure in order to convert the cellulosic material into a homogenous cellulosic fuel feedstock, recover other valuable byproducts, and dramatically reduce the volume of waste materials that must be sent to landfills.
Broadcast Interview
|
|
|
Dutch Gold Resources, Inc. (otc: DGRI)
Dutch Gold Resources, Inc. is a developer and operator of proven gold mines and a regional mill in North America. Dutch Gold Resources, Inc. acquired the Benton Mine, the Gold Bug Mine, and the permitted and operating mill from Dutch Mining LLC in 2007.
Broadcast Interview
|
|
